The US Food and Drug Administration has approved just one new systemic antibiotic drug since the launch of the 10 x '20 Initiative by the Infectious Diseases Society of America (IDSA) in 2010 despite a desperate shortage of new antibiotics to combat drug resistant bacteria. In a new report, published online today in iClinical Infectious Diseases/i, IDSA identified only seven new drugs in development for the treatment of infections caused by multidrug-resistant ...Sunday 21 April 2013
Development of New Antibiotics is Slow Despite Increasing Dangers of Superbugs
The US Food and Drug Administration has approved just one new systemic antibiotic drug since the launch of the 10 x '20 Initiative by the Infectious Diseases Society of America (IDSA) in 2010 despite a desperate shortage of new antibiotics to combat drug resistant bacteria. In a new report, published online today in iClinical Infectious Diseases/i, IDSA identified only seven new drugs in development for the treatment of infections caused by multidrug-resistant ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment